New Study on Fixed Airways Obstruction Among Patients With Severe Asthma … – Lung Disease News


Lung Disease News

New Study on Fixed Airways Obstruction Among Patients With Severe Asthma
Lung Disease News
Asthma is a chronic inflammatory disease of the airways and is characterized by reversible airflow obstruction in response to bronchodilators or inhaled corticosteroids. The most severe cases, accounting for 5% of all asthma cases, are associated with

View full post on asthma – Google News

CLINICAL PHARMACOLOGY STUDY OF A FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 50µg PLUS FORMOTEROL FUMARATE 6 µg VERSUS THE FREE COMBINATION OF BECLOMETHASONE HFA pMDI AND FORMOTEROL HFA pMDI AVAILABLE ON THE MARKET USING THE AEROCHAMBER PLUS™ SPACER DEVICE IN ASTHMATIC CHILDREN

Condition:   Asthma
Interventions:   Drug: CHF1535 pMDI + AC Plus;   Drug: BDP and Formoterol + AC Plus
Sponsors:   Chiesi Farmaceutici S.p.A.;   Chiesi Farmaceutici S.p.A.
Completed – verified April 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days